SCHEMBL6895034

SCHEMBL6895034

COC(=O)c1cccc2c1c1c(O)cc(C(C)C)cc1n2Cc1cccc(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 3/20 0.40
GLA P06280 1/20 0.40
F10 P00742 2/20 0.38
KDM4E B2RXH2 3/20 0.38
GAA P10253 2/20 0.38
STAT1 P42224 1/20 0.38
RAB9A P51151 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90B1 P14625 1/20 0.38
S1PR3 Q99500 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
POLB P06746 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6694748 0.90 MAPT (0.43) MAPTKDM4EGAAALDH1A1SMN1; SMN2
SCHEMBL6895041 0.89 MAPT (0.45) L3MBTL1MAPTKDM4EGAAALDH1A1
SCHEMBL6895778 0.89 PLA2G2A (0.45) MAPTF10ALDH1A1POLBCYP2D6
SCHEMBL6897629 0.89 POLB (0.36) MAPTF10POLBTP53P2RX7
SCHEMBL6776450 0.88 LMNA (0.39) LMNAGLAF10GAAPOLB
SCHEMBL6895899 0.88 PPARG (0.43) MAPTF10KDM4EALDH1A1SMN1; SMN2
SCHEMBL6689284 0.88 L3MBTL1 (0.49) L3MBTL1MAPTLMNAGLAF10
SCHEMBL6894722 0.88 PLA2G2A (0.41) MAPTGAAALDH1A1
SCHEMBL6890656 0.88 THRB (0.37) MAPTF10GAAALDH1A1
SCHEMBL6688534 0.87 MAPT (0.45) L3MBTL1MAPTLMNAGLAF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed